BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28915391)

  • 1. Hepatitis B surface antigen incorporated in dissolvable microneedle array patch is antigenic and thermostable.
    Poirier D; Renaud F; Dewar V; Strodiot L; Wauters F; Janimak J; Shimada T; Nomura T; Kabata K; Kuruma K; Kusano T; Sakai M; Nagasaki H; Oyamada T
    Biomaterials; 2017 Nov; 145():256-265. PubMed ID: 28915391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.
    Guo L; Qiu Y; Chen J; Zhang S; Xu B; Gao Y
    Biomed Microdevices; 2013 Dec; 15(6):1077-85. PubMed ID: 23893014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination.
    Chen F; Yan Q; Yu Y; Wu MX
    J Control Release; 2017 Jun; 255():36-44. PubMed ID: 28390901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
    Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
    Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
    Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
    Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN.
    Qiu Y; Guo L; Zhang S; Xu B; Gao Y; Hu Y; Hou J; Bai B; Shen H; Mao P
    Drug Deliv; 2016 Sep; 23(7):2391-2398. PubMed ID: 25625495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.
    Vrdoljak A; Allen EA; Ferrara F; Temperton NJ; Crean AM; Moore AC
    J Control Release; 2016 Mar; 225():192-204. PubMed ID: 26774221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
    Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R
    Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice.
    van der Maaden K; Varypataki EM; Romeijn S; Ossendorp F; Jiskoot W; Bouwstra J
    Eur J Pharm Biopharm; 2014 Oct; 88(2):310-5. PubMed ID: 24820032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
    Widera G; Johnson J; Kim L; Libiran L; Nyam K; Daddona PE; Cormier M
    Vaccine; 2006 Mar; 24(10):1653-64. PubMed ID: 16246466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
    Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
    Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameter optimization toward optimal microneedle-based dermal vaccination.
    van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
    Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
    Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ
    Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adjuvant on pharmacokinetics, organ distribution and humoral immunity of hepatitis B surface antigen after intramuscular injection to rats.
    Jeong EJ; Maeng HJ; Lee HJ; Kim Y; Kim CK
    Arch Pharm Res; 2012 Sep; 35(9):1621-8. PubMed ID: 23054719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination.
    Boopathy AV; Mandal A; Kulp DW; Menis S; Bennett NR; Watkins HC; Wang W; Martin JT; Thai NT; He Y; Schief WR; Hammond PT; Irvine DJ
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16473-16478. PubMed ID: 31358641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.
    Andrianov AK; DeCollibus DP; Gillis HA; Kha HH; Marin A; Prausnitz MR; Babiuk LA; Townsend H; Mutwiri G
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):18936-41. PubMed ID: 19864632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
    Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
    Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RLJ-NE-299A: a new plant based vaccine adjuvant.
    Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
    Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.